Sigma-Aldrich Corporation Launches an Addition to Its Line of Proteomics Standards

ST. LOUIS, Oct. 8 /PRNewswire-FirstCall/ -- Sigma-Aldrich proudly announces the launch of the new Proteomics Dynamic Range Standard (UPS2). We believe this is one of the most complex protein standards commercially available and that proteomics researchers now have a tool spanning a dynamic range to harmonize their research. The standard enables researchers to verify, challenge and troubleshoot their proteomics strategy as well as compare results with other labs.

The Proteomics Dynamic Range Standard is an enhancement of Sigma-Aldrich’s original Universal Proteomics Standard (designed in collaboration with the Association of Biomolecular Resource Facilities, or ABRF, and launched in 2006). The same 48 human proteins have been HPLC-purified and formulated into a dynamic range of concentrations from 0.5 fmoles to 50 pmoles. This standard is the latest addition to Sigma-Aldrich’s growing portfolio of proteomics standards.

“I believe the availability of a dynamic range standard like the UPS2 is invaluable for proteomics research, both for validating existing methodologies as well as developing new ones. I am pleased that Sigma-Aldrich has continued to extend their line of proteomics standards to address the quantification and dynamic range needs of proteomics researchers,” said Dr. Phil Andrews, Professor, University of Michigan Medical School Department of Biological Chemistry.

“Successfully bringing new standards to market has been a significant investment and research project from our proteomics research team. We are very proud of our scientific abilities to be able to offer this innovative tool for proteomics research,” said Tim Fleming, Director, Global Commercial Marketing - Life Science for Sigma-Aldrich.

http://www.sigma-aldrich.com/ups2

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 7,700 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award- winning Web site at http://www.sigma-aldrich.com.

Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Company’s expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Company’s operations and conditions in the markets the Company serves. The Company does not undertake any obligation to update these forward-looking statements.

CONTACT: Sean Battles of Sigma-Aldrich, +1-314-286-7616,
sean.battles@sial.com

Web site: http://www.sigma-aldrich.com//

MORE ON THIS TOPIC